Compliance with antipsychotic medication: From theory to practice

Journal of Mental Health

Volumn 6, Issue 5, 1997, Pages 473-489

  Hughes, Ian ^a,b   Hill, Brett ^a   Budd, Rick ^a  

^a Cardiff Comm Healthcare NHS Trust   (United Kingdom)

^b WHITCHURCH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; REVIEW; SCHIZOPHRENIA; TREATMENT PLANNING;

EID: 0030777421     PISSN: 09638237     EISSN: None     Source Type: Journal    
DOI: 10.1080/09638239718572     Document Type: Review

References (56)

1. Abbati, J. & Oles, G. (1993). Continuity of care in serious mental illness. Psychiatric Bulletin, 17, 140-141.
2. Adams, S.G. & Howe, J.T. (1993). Predicting medication compliance in a psychotic population. Journal of Nervous and Mental Disease, 181, 558-560.
3. Amador, X.F. & Strauss, D.H. (1993). Poor insight in schizophrenia. Psychiatric Quarterly, 64, 305-318.
4. Awad, G.A. (1993). Subjective response to neuroleptics in Schizophrenia. Schizophrenia Bulletin, 19, 609-618.
5. Barnes, R.E., Christopher, J. & McEvedy, B. (1996). Management of treatment resistant schizophrenia unresponsive to clozapine. British Journal of Psychiatry, 169, 31-40.
6. Bartko, G., Herczeg, I. & Zader, G. (1988). Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatrica Scandinavica, 77, 74-76.
7. Bebbington, P.E. (1995). The content and context of compliance. International Clinical Psychopharmacology, 9 , 41-50.
8. Brown, C.S., Wright, R.G. & Christensen, D.B. (1987). Association between type of medication instruction and patients' knowledge, side-effects and compliance. Hospital and Community Psychiatry, 38, 55-60.
9. Buchanan, A. (1992). A two year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine, 22, 787-797.
10. Buchanan, A. & David, A. (1994) Compliance and the reduction of dangerousness. Journal of Mental Health, 3, 427-429.
11. Budd, R.J. & Hughes, I.C.T. (1997). What do the carers of people with schizophrenia find helpful about psychoeducation? Clinical Psychology and Psychotherapy, 4, 118-124.
12. Budd, R.J., Hughes, I.C.T. & Smith, J.A. (1996). Health beliefs and compliance with antipsychotic medication. British Journal of Clinical Psychology, 35, 393-397.
13. Conway, S.P., Pond, M.N. & Hamnett, T. (1996). Compliance with treatment in adult patients with cystic fibrosis. Thorax, 51, 29-33.
14. Curson, D.A., Barnes, T.R.E., Bamber, R.W., Platt, S.D., Hirsch, S.R. & Duffy, J.C. (1985). Long-term depot maintenance of chronic schizophrenic outpatients: The seven year follow-up of the MRC fluphenazine/placebo trial. II: The incidence of compliance problems, side-effects, neurotic symptoms and depression. British Journal of Psychiatry, 146, 469-474.
15. Day, J.C., Wood, G., Dewey, M. & Bentall, R.P. (1995). A self-rating scale for measuring neuroleptic side-effects: Validation in a group of schizophrenic patients. British Journal of Psychiatry, 166, 650-653.
16. Donovan, J.L. & Blake, D.R. (1992). Patient non-compliance: Deviance or reasoned decision-making? Social Science and Medicine, 34, 507-13.
17. DTB (1994). Long-term management of people with psychotic disorders in the community. Drug and Therapeutics Bulletin, 32, 73-77.
18. Falloon, I.R.H. (1984). Developing and maintaining adherence to long-term drug-taking regimens. Schizophrenia Bulletin, 10, 412-417.
19. Fleischhaker, W.W., Meise, U., Gunther, V. & Kurz, M. (1994). Compliance with antipsychotic drug treatment: Influence of side-effects. Acta Psychiatrica Scandinavica, 89, 11-15.
20. Fowler, D., Garety, P. & Kuipers, E. (1995). Cognitive behaviour therapy for psychosis: Theory and practice. Chichester: Wiley.
21. Frank, A.F. & Gunderson, J.G. (1990). The role of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry, 47, 228-236.
22. Gunderson, J.G., Frank, A.F., Katz, H.M., Vannicelli, M.L., Frosch, J.P. & Knapp, P.H. (1984). Effects of psychotherapy in schizophrenia II: Comparative outcome of two forms of treatment. Schizophrenia Bulletin, 10, 564-598.
23. Hoge, S.K., Appelbaum, P.S., Lawlor, T., Beck, J.C., Litman, R., Greer, A., Gutheil, T.G. & Kaplan, E. (1990). A prospective, multicenter study of patients' refusal of antipsychotic medication. Archives of General Psychiatry, 47, 949-956.
24. Hogan, T.P., Awad, A.G. & Eastwood, R. (1983). A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychological Medicine, 13, 177-183.
25. Hogarty, G.E., Anderson, C.M., Reis, D.J., Korblinth, S.J., Greenwald, D.P., Ulrich, R.F. & Carter, M. (1991). Family psychoeducation, social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia. Archives of General Psychiatry, 48, 340-347.
26. Janz, N.K., & Becker, M.H. (1984). The Health Belief Model: A decade later. Health Education Quarterly, 11, 1-47.
27. Johnson, D.W.A. (1983). Depression: Treatment compliance in general practice. Acta Psychiatrica Scandanavica, 63, 447-453.
28. Kelly, G.R., Mamon, J.A., & Scott, J.E. (1987). Utility of the Health Belief Model in examining medication compliance among psychiatric outpatients. Social Science and Medicine, 25, 1205-1211.
29. Kelly, G.R. & Scott, J.E. (1990). Medication compliance and health education among outpatients with chronic mental disorders. Medical Care, 28, 1181-1197.
30. Kemp, R. & David, A. (1995). Psychosis: Insight and compliance. Current Opinion in Psychiatry, 8, 357-361.
31. Kemp, R., Hayward, P., Applewhaite, G., Everitt, B. & David, A. (1996a). Compliance therapy in psychotic patients: Randomised controlled trial. British Medical Journal, 312, 345-349.
32. Kemp, R., David, A. & Hayward, P. (1996b). Compliance therapy: An intervention targeting insight and treatment adherence in psychotic patients. Behavioural and Cognitive Psychotherapy, 24, 331-350.
33. Ley, P. & Llewellyn, S. (1995). Improving patients' understanding, recall, satisfaction and compliance. In: A. Broome & S. Llewellyn (eds) Health psychology: Process and applications. London: Croom Helm.
34. Ley, P. (1988). Communicating with patients. London: Croom Helm.
35. Ludwig, W., Huber, D., Schmidt, S., Bender, W. & Greil, W. (1990). Assessment of compliance-related attitudes in psychiatry: A comparison of two questionnaires based on the health belief model. Social Psychiatry and Psychiatric Epidemiology, 25, 298-303.
36. Macpherson, R., Jerrom, B. & Hughes, A. (1996). A controlled study of education about drug treatment in Schizophrenia. British Journal of Psychiatry, 168, 709-717.
37. Macpherson, R. & Jerrom, B. (1997). Drug refusal among schizophrenic patients treated in the community. Journal of Mental Health, 6, 141-147.
38. McGavock, H., Britten, N. & Weinman, J. (1996). A review of the literature on drug adherence. London: Royal Pharmaceutical Society of Great Britain.
39. Morris, L.S. & Schulz, R.M. (1993). Medication compliance: The patient's perspective. Clinical Therapeutics, 15, 593-606.
40. Myers, E.D. & Braithwaite, A. (1992). Outpatient compliance with antidepressant medication. British Journal of Psychiatry, 160, 83-86.
41. Pan, P. & Tantam, D. (1989). Clinical characteristics, health beliefs and compliance with maintenance treatment: A comparison between regular and irregular attenders at a depot clinic. Acta Psychiatrica Scandinavica, 79, 564-570.
42. Pool, E.V. & Elder, S.T. (1986). A selected review of the literature on an empirical analysis of drug treatment compliance by schizophrenic patients. International Review of Applied Psychology, 35, 547-576.
43. Pullar, T. & Feely, M. (1990). Problems of compliance with drug treatment: New solutions? The Pharmaceutical Journal, August 18th, 213-15.
44. Pullar, T., Kumar, S., & Peaker, S. (1990). Patterns of compliance in hypertension. British Journal of Clinical Pharmacology, 30, 381.
45. Raynor, D.K. (1992). Patient compliance: The pharmacist's role. International Journal of Pharmacy Practice, 1, 126-35.
46. Rollnick, S., Bell, A., & Heather, N. (1992). Negotiating behaviour change in medical settings: The development of brief motivational interviewing. Journal of Mental Health, 1, 25-37.
47. Rollnick, S. & Miller, W.R. (1995). What is motivational interviewing? Behavioural and Cognitive Psychotherapy, 23, 325-334.
48. Rudd, P., Bynny, RL., & Zachary, V. (1989). The natural history of medication compliance in a drug trial: Limitations of pill counts. Clinical Pharmacology and Therapeutics, 46, 169-176.
49. Sellwood, W. & Tarrier, N. (1994). Demographic factors associated with extreme non-compliance in schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 29, 172-177.
50. Seltzer, A., Roncari, I. & Garfinkel, P. (1980). Effect of patient education on medication compliance. Canadian Journal of Psychiatry, 25, 639-645.
51. Smith, J.V., Birchwood, M.J. & Hadrell, A. (1992). Informing people with schizophrenia about their illness: The effect of residual symptoms. Journal of Mental Health, 1, 61-70.
52. Van Putten, T. (1974). Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry, 31, 67-72.
53. Van Putten, T., Crumpton, E. & Yale, C. (1976). Drug refusal in schizophrenics and the wish to be crazy. Archives of General Psychiatry, 33, 1443-1446.
54. Weiden, P., Rapkin, B., Mott, T., Zygmunt, A., Goldman, D., Horvitz-Lennon, M. & Frances, A. (1994). Rating of medication influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin, 20, 297-307.
55. Weiden, P. & Olfsen, M. (1995). Cost of relapse in schizophrenia. Schizophrenia Bulletin, 21, 419-429.
56. Xiang, M., Ran, M., & Li, S. (1994). A controlled evaluation of psychoeducational family intervention in a rural Chinese community. British Journal of Psychiatry, 165, 544-548.